Mon-20-04-2015, 15:32 PM
They didn't report secondary end point? Shame on them...
Ixekizumab meets it's goals in Phase 3 for psoriatic arthritis.
|
« Next Oldest | Next Newest »
|
Messages In This Thread |
Ixekizumab meets it's goals in Phase 3 for psoriatic arthritis. - by Fred - Mon-20-04-2015, 14:48 PM
RE: Ixekizumab meets it's goals in Phase 3 for psoriatic arthritis. - by mataribot - Mon-20-04-2015, 15:32 PM
RE: Ixekizumab meets it's goals in Phase 3 for psoriatic arthritis. - by jiml - Mon-20-04-2015, 15:34 PM
|
Possibly Related Threads… | |||||
Thread | Author | Replies | Views | Last Post | |
CAL101 phase 1 on patients with psoriasis | Fred | 6 | 868 |
Fri-25-10-2024, 15:51 PM Last Post: Fred |
|
Bimzelx vs Skyrizi study for psoriatic arthritis | Fred | 0 | 524 |
Mon-30-09-2024, 14:22 PM Last Post: Fred |
|
Piclidenoson for psoriasis phase 3 results | Fred | 1 | 3,240 |
Fri-02-02-2024, 20:04 PM Last Post: Caroline |
|
JNJ-2113 for psoriasis Phase 2b results | Fred | 4 | 3,494 |
Wed-12-07-2023, 11:52 AM Last Post: Turnedlight |
|
Bimzelx gets recommendation for psoriatic arthritis in the EU | Fred | 2 | 2,666 |
Sat-10-06-2023, 14:33 PM Last Post: Forest Walker |